View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBlackmores 将来の成長Future 基準チェック /46Blackmoresは、22%と8.8%でそれぞれ年率22%で利益と収益が成長すると予測される一方、EPSはgrowで21.7%年率。主要情報22.0%収益成長率21.71%EPS成長率Personal Products 収益成長8.5%収益成長率8.8%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日14 Aug 2023今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesUpcoming Dividend • Jul 18Upcoming dividend of AU$3.29 per share at 1.3% yieldEligible shareholders must have bought the stock before 25 July 2023. Payment date: 01 August 2023. Payout ratio is a comfortable 67% but the company is paying out more than the cash it is generating. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (1.9%).お知らせ • Jul 13Blackmores Limited Announces Fully Franked Special Dividend, Payable on 1 August 2023Blackmores Limited provided the following update in relation to the proposed Scheme of Arrangement (Scheme) under which all of the issued shares in Blackmores will be acquired by Kirin Health Science Australia Pty Ltd. (Kirin Sub), a wholly owned subsidiary of Kirin Holdings Company, Limited (Kirin). The Blackmores Directors have determined to pay a fully franked special dividend of $3.29 (Special Dividend) in respect of Blackmores Shares held on the record date for the Special Dividend, being 7:00pm (Sydney time) on 26 July 2023. Payment of the Special Dividend is conditional on the Scheme becoming effective. If the Scheme becomes effective, payment of the Special Dividend is expected to occur on 1 August 2023. In addition to the Special Dividend and subject to the Scheme becoming legally effective, Blackmores Shareholders will also be sent $91.71 cash per Blackmores Share on the Implementation Date for the Scheme (expected to be 10 August 2023) in respect of Blackmores Shares held at 7:00pm on 2 August 2023.Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €55.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 24x in the Personal Products industry in Europe. Total returns to shareholders of 21% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €45.52 per share.Upcoming Dividend • Mar 01Upcoming dividend of AU$0.87 per share at 1.2% yieldEligible shareholders must have bought the stock before 08 March 2023. Payment date: 28 March 2023. Payout ratio is a comfortable 67% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (2.2%).Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$1.25 (vs AU$1.05 in 1H 2022)First half 2023 results: EPS: AU$1.25 (up from AU$1.05 in 1H 2022). Revenue: AU$338.7m (down 2.4% from 1H 2022). Net income: AU$24.3m (up 20% from 1H 2022). Profit margin: 7.2% (up from 5.8% in 1H 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Personal Products industry in Europe.お知らせ • Jan 19+ 2 more updatesBlackmores Limited to Report First Half, 2023 Results on Feb 23, 2023Blackmores Limited announced that they will report first half, 2023 results on Feb 23, 2023Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to €55.50, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 23x in the Personal Products industry in Europe. Total returns to shareholders of 7.9% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €53.57 per share.Buying Opportunity • Dec 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be €56.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.5% over the last 3 years. Earnings per share has declined by 18%. For the next 3 years, revenue is forecast to grow by 8.6% per annum. Earnings is also forecast to grow by 21% per annum over the same time period.Board Change • Nov 17High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. CEO, MD & Director Alastair Symington is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Upcoming Dividend • Aug 24Upcoming dividend of AU$0.32 per shareEligible shareholders must have bought the stock before 31 August 2022. Payment date: 19 September 2022. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (2.1%).Valuation Update With 7 Day Price Move • Aug 24Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €46.00, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Personal Products industry in Europe. Total loss to shareholders of 1.5% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €80.79 per share.Reported Earnings • Aug 19Full year 2022 earnings released: EPS: AU$1.58 (vs AU$1.24 in FY 2021)Full year 2022 results: EPS: AU$1.58 (up from AU$1.24 in FY 2021). Revenue: AU$651.2m (up 13% from FY 2021). Net income: AU$30.6m (up 28% from FY 2021). Profit margin: 4.7% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.6%, compared to a 8.0% growth forecast for the Personal Products industry in Germany.Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. 1 highly experienced director. Independent & Non-Executive Director David Ansell is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Buying Opportunity • Apr 02Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 17%. The fair value is estimated to be €62.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 50%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings is also forecast to grow by 30% per annum over the same time period.Upcoming Dividend • Mar 15Upcoming dividend of AU$0.63 per shareEligible shareholders must have bought the stock before 22 March 2022. Payment date: 12 April 2022. Payout ratio is a comfortable 67% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.6%). Lower than average of industry peers (2.3%).Reported Earnings • Feb 26First half 2022 earnings: EPS in line with expectations, revenues disappointFirst half 2022 results: EPS: AU$1.05 (up from AU$0.73 in 1H 2021). Revenue: AU$346.0m (up 14% from 1H 2021). Net income: AU$20.3m (up 44% from 1H 2021). Profit margin: 5.9% (up from 4.7% in 1H 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 13%, compared to a 8.5% growth forecast for the industry in Germany.Recent Insider Transactions • Nov 14Independent Non-Executive Director recently bought €96k worth of stockOn the 11th of November, Erica Mann bought around 1k shares on-market at roughly €64.56 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €267k more in shares than they have sold in the last 12 months.Board Change • Nov 01High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. 1 highly experienced director. Independent & Non-Executive Director David Ansell is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Oct 02High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Independent & Non-Executive Director David Ansell is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.Reported Earnings • Aug 27Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$590.0m (up 3.2% from FY 2020). Net income: AU$24.0m (up 58% from FY 2020). Profit margin: 4.1% (up from 2.6% in FY 2020). The increase in margin was driven by higher revenue.業績と収益の成長予測DB:B5E - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数6/30/2026880869810816/30/202582169829236/30/202475155587236/30/2023677415365312/31/202264535819N/A9/30/2022648332334N/A6/30/2022651313848N/A3/31/2022634303649N/A12/31/2021619303549N/A9/30/2021599273754N/A6/30/2021578244058N/A3/31/202157817N/AN/AN/A12/31/202057895768N/A9/30/2020573114862N/A6/30/2020568123956N/A3/31/202056421N/AN/AN/A12/31/2019567341338N/A9/30/201958643N/AN/AN/A6/30/201959351020N/A3/31/201962863N/AN/AN/A12/31/2018634704564N/A9/30/201862271N/AN/AN/A6/30/2018602704258N/A3/31/201858367N/AN/AN/A12/31/2017577656376N/A9/30/201756162N/AN/AN/A6/30/2017553593146N/A3/31/201756368N/AN/AN/A12/31/201657980-122N/A9/30/201658589N/AN/AN/A6/30/2016598100N/A84N/A3/31/201667791N/AN/AN/A12/31/201546576N/A102N/A9/30/201553561N/AN/AN/A6/30/201538847N/A71N/A3/31/201541939N/AN/AN/A12/31/201438432N/A53N/A9/30/201436129N/AN/AN/A6/30/201434725N/A37N/A3/31/201434024N/AN/AN/A12/31/201333224N/A33N/A9/30/201332623N/AN/AN/A6/30/201332725N/A22N/A3/31/201331626N/AN/AN/A12/31/201229827N/A13N/A9/30/201228028N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: B5Eの予測収益成長率 (年間22% ) は 貯蓄率 ( 0.4% ) を上回っています。収益対市場: B5Eの収益 ( 22% ) はGerman市場 ( 16.8% ) よりも速いペースで成長すると予測されています。高成長収益: B5Eの収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: B5Eの収益 ( 8.8% ) German市場 ( 6.6% ) よりも速いペースで成長すると予測されています。高い収益成長: B5Eの収益 ( 8.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: B5Eの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/08/15 20:30終値2023/07/21 00:00収益2022/12/31年間収益2022/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Blackmores Limited 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関Sriharsh SinghBofA Global ResearchAnna GuanCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.Alva DeVoyCGS International9 その他のアナリストを表示
Upcoming Dividend • Jul 18Upcoming dividend of AU$3.29 per share at 1.3% yieldEligible shareholders must have bought the stock before 25 July 2023. Payment date: 01 August 2023. Payout ratio is a comfortable 67% but the company is paying out more than the cash it is generating. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (1.9%).
お知らせ • Jul 13Blackmores Limited Announces Fully Franked Special Dividend, Payable on 1 August 2023Blackmores Limited provided the following update in relation to the proposed Scheme of Arrangement (Scheme) under which all of the issued shares in Blackmores will be acquired by Kirin Health Science Australia Pty Ltd. (Kirin Sub), a wholly owned subsidiary of Kirin Holdings Company, Limited (Kirin). The Blackmores Directors have determined to pay a fully franked special dividend of $3.29 (Special Dividend) in respect of Blackmores Shares held on the record date for the Special Dividend, being 7:00pm (Sydney time) on 26 July 2023. Payment of the Special Dividend is conditional on the Scheme becoming effective. If the Scheme becomes effective, payment of the Special Dividend is expected to occur on 1 August 2023. In addition to the Special Dividend and subject to the Scheme becoming legally effective, Blackmores Shareholders will also be sent $91.71 cash per Blackmores Share on the Implementation Date for the Scheme (expected to be 10 August 2023) in respect of Blackmores Shares held at 7:00pm on 2 August 2023.
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €55.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 24x in the Personal Products industry in Europe. Total returns to shareholders of 21% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €45.52 per share.
Upcoming Dividend • Mar 01Upcoming dividend of AU$0.87 per share at 1.2% yieldEligible shareholders must have bought the stock before 08 March 2023. Payment date: 28 March 2023. Payout ratio is a comfortable 67% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (2.2%).
Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$1.25 (vs AU$1.05 in 1H 2022)First half 2023 results: EPS: AU$1.25 (up from AU$1.05 in 1H 2022). Revenue: AU$338.7m (down 2.4% from 1H 2022). Net income: AU$24.3m (up 20% from 1H 2022). Profit margin: 7.2% (up from 5.8% in 1H 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Personal Products industry in Europe.
お知らせ • Jan 19+ 2 more updatesBlackmores Limited to Report First Half, 2023 Results on Feb 23, 2023Blackmores Limited announced that they will report first half, 2023 results on Feb 23, 2023
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to €55.50, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 23x in the Personal Products industry in Europe. Total returns to shareholders of 7.9% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €53.57 per share.
Buying Opportunity • Dec 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be €56.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.5% over the last 3 years. Earnings per share has declined by 18%. For the next 3 years, revenue is forecast to grow by 8.6% per annum. Earnings is also forecast to grow by 21% per annum over the same time period.
Board Change • Nov 17High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. CEO, MD & Director Alastair Symington is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Upcoming Dividend • Aug 24Upcoming dividend of AU$0.32 per shareEligible shareholders must have bought the stock before 31 August 2022. Payment date: 19 September 2022. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (2.1%).
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €46.00, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Personal Products industry in Europe. Total loss to shareholders of 1.5% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €80.79 per share.
Reported Earnings • Aug 19Full year 2022 earnings released: EPS: AU$1.58 (vs AU$1.24 in FY 2021)Full year 2022 results: EPS: AU$1.58 (up from AU$1.24 in FY 2021). Revenue: AU$651.2m (up 13% from FY 2021). Net income: AU$30.6m (up 28% from FY 2021). Profit margin: 4.7% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.6%, compared to a 8.0% growth forecast for the Personal Products industry in Germany.
Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. 1 highly experienced director. Independent & Non-Executive Director David Ansell is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Buying Opportunity • Apr 02Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 17%. The fair value is estimated to be €62.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 50%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings is also forecast to grow by 30% per annum over the same time period.
Upcoming Dividend • Mar 15Upcoming dividend of AU$0.63 per shareEligible shareholders must have bought the stock before 22 March 2022. Payment date: 12 April 2022. Payout ratio is a comfortable 67% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.6%). Lower than average of industry peers (2.3%).
Reported Earnings • Feb 26First half 2022 earnings: EPS in line with expectations, revenues disappointFirst half 2022 results: EPS: AU$1.05 (up from AU$0.73 in 1H 2021). Revenue: AU$346.0m (up 14% from 1H 2021). Net income: AU$20.3m (up 44% from 1H 2021). Profit margin: 5.9% (up from 4.7% in 1H 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 13%, compared to a 8.5% growth forecast for the industry in Germany.
Recent Insider Transactions • Nov 14Independent Non-Executive Director recently bought €96k worth of stockOn the 11th of November, Erica Mann bought around 1k shares on-market at roughly €64.56 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €267k more in shares than they have sold in the last 12 months.
Board Change • Nov 01High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. 1 highly experienced director. Independent & Non-Executive Director David Ansell is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Oct 02High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Independent & Non-Executive Director David Ansell is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Director Overboarding • Sep 01Director Sharon Warburton has joined 5th company boardSharon Warburton has been appointed to the board of Northern Star Resources Limited (ASX:NST). Warburton now sits on a total of 5 company boards. According to the Simply Wall St Risk Model, the director is at risk of having too many board obligations.
Reported Earnings • Aug 27Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$590.0m (up 3.2% from FY 2020). Net income: AU$24.0m (up 58% from FY 2020). Profit margin: 4.1% (up from 2.6% in FY 2020). The increase in margin was driven by higher revenue.